Text Size

Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Merck
Information provided by:
Danish Cancer Society
ClinicalTrials.gov Identifier:
NCT00932009
First received: June 30, 2009
Last updated: NA
Last verified: June 2009
History: No changes posted
  Purpose

The purpose of this study is to determine the prevalence and type distribution of genital human papillomavirus (HPV) infection in Tanzanian men.


Condition
Human Papillomavirus Infection

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Prevalence and Type Distribution of Genital Human Papillomavirus (HPV) in Tanzanian Men

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Danish Cancer Society:

Primary Outcome Measures:
  • HPV infection [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • HIV infection

Biospecimen Retention:   Samples With DNA

cell scrapes from penis


Estimated Enrollment: 2000
Study Start Date: March 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
Human papillomavirus
Tanzanian men with HPV and Tanzanian men without

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Tanzanian men from an urban setting (Dar es Sallam)(factories, University, college)and men from an rural setting (Muhesa, Mwanga, Bagamoyo)

Criteria

Inclusion Criteria:

  • men who are able to understand the information about the study (in writing or oral)

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00932009

Locations
Denmark
Inst. of Cancer Epidemiology, Danish Cancer Society
Copenhagen, Denmark, DK-2100
Sponsors and Collaborators
Danish Cancer Society
Merck
Investigators
Principal Investigator: Susanne K. Kjaer, Professor, MD., DMSc. Inst. of Cancer Epidemiology,Danish Cancer Society
  More Information

No publications provided

Responsible Party: Susanne Krüger Kjaer/Professor, MD., DMSc., Institute of Cancer Epidemiology, Danish Cancer Society
ClinicalTrials.gov Identifier: NCT00932009     History of Changes
Other Study ID Numbers: HPV IISP #36113
Study First Received: June 30, 2009
Last Updated: June 30, 2009
Health Authority: Tanzania: Ministry of Health
Tanzania: National Institute for Medical Research

Keywords provided by Danish Cancer Society:
Human papillomavirus infection
Tanzanian men
Prevalence

Additional relevant MeSH terms:
Warts
Papillomavirus Infections
DNA Virus Infections
Virus Diseases
Skin Diseases, Viral
 Tumor Virus Infections
Neoplasms
Skin Diseases, Infectious
Skin Diseases

ClinicalTrials.gov processed this record on May 22, 2013